Select Medical Q1 net income drops 59% to $55.9M; revenue up 3.4% to $1.60B

SELECT MEDICAL HOLDINGS CORP

2022-Q1 EPS reported $0.37 revenue$1,599,547,000

Adjusted EBITDA fell 37% to $163.8M from $258.3M; operating income $104.0M vs $202.0M.
EPS $0.37 vs $0.82; critical illness hospital segment Adjusted EBITDA margin fell to 6.0% from 19.0%.
Dividend of $0.125 per share declared; payable June 1, 2022 to holders of record May 19, 2022.
Reaffirmed FY2022 revenue outlook $6.25B-$6.40B; labor climate cited for withholding EBITDA and EPS outlook.
Concentra segment Adjusted EBITDA up 9.1% to $89.5M with 21.1% margin; repurchased 2.1M shares in Q1.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.